September 2026
The drug discovery informatics market size stood at USD 5.35 billion in 2026, with major drug discovery informatics companies including collaborative drug discovery inc, eurofins discoverx products, jubilant biosys, selvita, novo informatics pvt ltd.
September 2026
The global drug discovery outsourcing market size was valued at USD 4.78 billion in 2026 and is projected to hit around USD 8.98 billion by 2035 with a CAGR of 7.27%.
September 2026
The global drug discovery market size was evaluated at USD 78.51 billion in 2026 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
September 2026
The drug discovery services market size was estimated at USD 27.89 billion in 2026 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
September 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
September 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.
September 2026
The computational medicine and drug discovery software market size reached USD 12.94 billion in 2026, with leading computational medicine and drug discovery software market companies including Entelos Inc., Crown Bioscience Inc., Chemical Computing Group Inc., Nimbus Therapeutics Inc.
September 2026
The U.S. drug discovery market generated USD 28.66 billion in 2026, with prominent U.S. drug discovery market companies including Johnson and Johnson, Pfizer Inc., Merck and Co.
September 2026
The CNS drug discovery market was valued at USD 10.86 billion in 2026, with leading companies including Eli Lilly and Company, Roche, Novartis, Pfizer, AbbVie.
July 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
May 2026
The global large molecule drug discovery outsourcing market size was evaluated at USD 3.20 billion in 2025 and is predicted to hit around USD 7.67 billion by 2035, growing at a CAGR of 9.14%.
March 2026
The global computer-aided drug discovery market size is projevted to hit around USD 14.38 billion by 2035 from USD 4.72 billion in 2025 with a CAGR of 11.78%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
January 2026
The generative AI in drug discovery market size reached USD 260.56 million in 2025 and is estimated to hit around USD 2,724.15 million by 2035, at a CAGR of 26.45%.
November 2025
The artificial intelligence (AI) in drug discovery market size is predicted to surpass around USD 17.81 billion by 2035 from USD 6.93 billion in 2025 with a solid CAGR of 9.90%.
September 2026
The pharma 4.0 market was valued at USD 23.16 billion in 2026, with leading companies including Matthews Specialty Vehicles, Farber Specialty Vehicles, Medical Coaches.
September 2026
The quantum computing in healthcare market was valued at USD 414.14 million in 2026, with leading companies including IBM, Microsoft, Google.
September 2026
The fetal bovine serum market was valued at USD 2.73 billion in 2026, with leading companies including TCS Biosciences Ltd, Merck KGaA, Gemini Bio-Products.
August 2025
The global pharmaceutical CRO market size was evaluated at USD 44.58 billion in 2024 and is projected to attain around USD 91.20 billion by 2034, with a CAGR of 7.42%.
September 2026
The bioinformatics market size reached USD 20.99 billion in 2026, with leading bioinformatics market companies including Thermo Fisher Scientific, Inc., Eurofins Scientific, Illumina, Inc.
September 2026
The asthma and COPD drugs market size reached USD 46.93 billion in 2026, with leading asthma and COPD drugs market companies including AstraZeneca, GlaxoSmithKline (GSK), Novartis.
September 2026
The RNA interference drug delivery market was worth USD 139.58 billion in 2026, with key RNA interference drug delivery market players including Dicerna Pharmaceuticals (Acquired by Novo Nordisk), Silence Therapeutics, Ionis Pharmaceuticals.
September 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
September 2026
The global albinism drug market size was evaluated at USD 292.88 million in 2026 and is predicted to hit around USD 439.01 million by 2035, growing at a CAGR of 4.60%.
September 2026
The global cardiovascular drugs market size is valued at USD 162.02 billion in 2026 and is expected to hit around USD 221.20 billion by 2035, growing at a CAGR of 3.56% from 2026 to 2035.
September 2026
The bioinformatics-as-a-Service (BaaS) market size reached USD 4.92 billion in 2026, with leading bioinformatics-as-a-Service (BaaS) market companies including Illumina, Inc., Thermo Fisher Scientific.
September 2026
The global materials informatics market size is calculated at USD 251.17 million in 2026 and expected to hit nearly USD 1,314.25 million by 2035, expanding at a strong CAGR of 20.22% from 2026 to 2035.
September 2026
The global subcutaneous drug delivery devices market size was valued at USD 38.87 billion in 2026 and is projected to hit around USD 74.66 billion by 2035 with a CAGR of 7.53%.
September 2026
The pulmonary drug delivery systems market size reached USD 61.03 billion in 2026, with leading pulmonary drug delivery systems market companies including Philips Respironics, GlaxoSmithKline PLC, BoehringerIngelheim GmbH.
September 2026
The global topical drug delivery market size was valued at USD 148.81 billion in 2026 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com